Guidance for Industry - Priority Review of Drug Submissions
This guidance aims to articulate Health Canada's expectations and generate a level of consistency regarding the interpretation of the Priority Review of Drug Submissions policy and the filing of a Priority Review request. Additional clarification of the process by which the Priority Review request is assessed is provided.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance for Industry - Priority Review of Drug SubmissionsHTMLEnglish publication HTML
-
Guidance for Industry - Priority Review of Drug SubmissionsHTMLFrench publication HTML
Similar records